Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus

被引：3

作者：

Cressey, Tim R. ^{[1
,2
,3
]}

Harrison, Linda ^{[4
]}

Achalapong, Jullapong ^{[5
]}

Kanjanavikai, Prateep ^{[6
]}

Ayudhaya, Orada Patamasingh Na ^{[7
]}

Liampongsabuddhi, Prateung ^{[8
]}

Siriwachirachai, Thitiporn ^{[9
]}

Putiyanun, Chaiwat ^{[10
]}

Suriyachai, Pornnapa

Tierney, Camlin ^{[4
]}

Salvadori, Nicolas ^{[1
]}

Chinwong, Dujrudee ^{[11
]}

Decker, Luc ^{[12
]}

Tawon, Yardpiroon ^{[1
]}

Murphy, Trudy V. ^{[13
]}

Ngo-Giang-Huong, Nicole ^{[1
,2
,12
]}

Siberry, George K. ^{[14
]}

Jourdain, Gonzague ^{[1
,2
,11
]}

机构：

[1] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, PHPT IRD, Chiang Mai, Thailand

[2] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA

[3] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England

[4] Harvard TH Chan Sch Publ Hlth, CBAR, Boston, MA USA

[5] Chiangrai Prachanukroh Hosp, Chiang Rai, Thailand

[6] Banglamung Hosp, Chon Buri, Thailand

[7] Nopparat Rajathanee Hosp, Bangkok, Thailand

[8] Lampang Hosp, Lampang, Thailand

[9] Khon Kaen Hosp, Khon Kaen, Thailand

[10] Chiang Kham Hosp, Phayao, Thailand

[11] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Care, Chiang Mai, Thailand

[12] IRD, Unite Mixte Int PHPT 174, Chiang Mai, Thailand

[13] Ctr Dis Control & Prevent, Atlanta, GA USA

[14] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2018年 / 62卷 / 12期

关键词：

pregnancy; tenofovir; hepatitis B virus; pharmacokinetics; CLINICAL-PHARMACOLOGY; PHARMACOKINETICS; HIV;

D O I：

10.1128/AAC.01686-18

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We assessed tenofovir exposure during pregnancy and postpartum in hepatitis B virus (HBV)-infected HIV-uninfected women receiving tenofovir disoproxil fumarate (TDF) to prevent mother-to-child transmission of HBV. Data from 154 women who received TDF within a randomized controlled trial were included. Individual plasma tenofovir exposures (area under the concentration-time curve from 0 to 24 h [AUC0-24]) were estimated using a population pharmacokinetic approach. The estimated geometric mean tenofovir AUC(0-24) was 20% (95% confidence interval [95% CI], 19 to 21%) lower during pregnancy than during postpartum; this modest reduction in the absence of HBV transmission suggests that no dose adjustment is needed.

引用

页数：5

共 50 条

[31] THE EFFICACY AND SAFETY OF TELBIVUDINE OR TENOFOVIR IN PREGNANCY FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HBV
Zhang, Y.
Wu, Q.
Huang, H.
Wang, Y.
[J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S607 - S607
[32] Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
Marieke Bierhoff
Chaisiri Angkurawaranon
Marcus J. Rijken
Kanlaya Sriprawa
Pachinee Kobphan
Francois N. Nosten
Michèle van Vugt
Rose McGready
Angela Devine
[J]. BMC Pregnancy and Childbirth, 21
[33] Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus (HBV)
Eke, Ahizechukwu
Yun, Xia
Eke, Uzoamaka
Eleje, George
Jiao, Liu
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S226 - S226
[34] Hepatitis B virus infection: Prevention of mother-to-child transmission and exacerbation during pregnancy
Sasagawa, Yuki
Yamada, Hideto
Morizane, Mayumi
Deguchi, Masashi
Shirakawa, Tokuro
Morioka, Ichiro
Tanimura, Kenji
[J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (08) : 621 - 625
[35] Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
Bierhoff, Marieke
Angkurawaranon, Chaisiri
Rijken, Marcus J.
Sriprawa, Kanlaya
Kobphan, Pachinee
Nosten, Francois N.
van Vugt, Michele
McGready, Rose
Devine, Angela
[J]. BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)
[36] Comparative Analysis of the Effect of Tenofovir and Telbivudine on Blocking Mother-to-Child Transmission of Hepatitis B Virus
Lin, Houxiong
Wang, Dezhi
[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 154 - 154
[37] Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus
Zhu, Bo
Lv, Xiaojing
Zhao, Zhiying
Chen, Liwen
Chen, Xiuli
Li, Congjie
Li, Suwen
Dai, Erhei
[J]. MEDICINE, 2021, 100 (44)
[38] Tenofovir Disoproxil Fumarate for Prevention of Vertical Transmission of Hepatitis B Virus Infection by Highly Viremic Pregnant Women: A Case Series
Calvin Q. Pan
Li-Jun Mi
Chalermrat Bunchorntavakul
Jeffrey Karsdon
William M. Huang
Gaurav Singhvi
Marc G. Ghany
K. Rajender Reddy
[J]. Digestive Diseases and Sciences, 2012, 57 : 2423 - 2429
[39] Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
Bukkems, Vera E.
Smolders, Elise J.
Jourdain, Gonzague
Burger, David M.
Colbers, Angela P.
Cressey, Tim R.
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (03): : 388 - 393
[40] Tenofovir Disoproxil Fumarate for Prevention of Vertical Transmission of Hepatitis B Virus Infection by Highly Viremic Pregnant Women: A Case Series
Pan, Calvin Q.
Mi, Li-Jun
Bunchorntavakul, Chalermrat
Karsdon, Jeffrey
Huang, William M.
Singhvi, Gaurav
Ghany, Marc G.
Reddy, K. Rajender
[J]. DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (09) : 2423 - 2429

← 1 2 3 4 5 →